903. Health Services and Quality Improvement: Myeloid Malignancies: Poster I

Impact of hospital admissions through the emergency department versus direct admissions for patients with hematologic malignancies A single site analysis

Longitudinal trends 1999–2023 and forecasted mortality 2024–2030 in sepsis associated mortality among patients with Myelodysplastic Syndromes in the United States

Aromatherapy oil during bone marrow biopsy procedure and association with anxiety and pain An interim analysis

Socioeconomic disparities in the receipt of allogeneic stem cell transplantation among patients with relapsed Acute Myeloid Leukemia A national inpatient sample analysis 2016–2020

Trends and disparities in myelodysplastic Syndrome–Associated mortality in the u S from 1999 to 2020 A population based study using the CDC wonder database

Disparities in diagnosis and management of myelodysplastic syndromes in a brazilian cancer center A comparison between public and private healthcare systems

Patient and clinician perspectives on the diagnosis and management of polycythemia vera Results from concurrent surveys

Real world rates of tyrosine kinase inhibitor prescription approval fill and adherence and associated factors in a national sample of patients with chronic myeloid leukemia

Healthcare resource utilization in patients receiving quizartinib or placebo in combination with chemotherapy for newly diagnosed FLT3 ITD acute myeloid leukemia An analysis from the QuANTUM first trial

Inclusive practices for safe and equitable donor assessment